These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
712 related articles for article (PubMed ID: 9166284)
1. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284 [TBL] [Abstract][Full Text] [Related]
2. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005 [TBL] [Abstract][Full Text] [Related]
3. Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts. Li H; Bauzon DE; Xu X; Tschesche H; Cao J; Sang QA Mol Carcinog; 1998 Jun; 22(2):84-94. PubMed ID: 9655252 [TBL] [Abstract][Full Text] [Related]
4. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064 [TBL] [Abstract][Full Text] [Related]
5. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. Gilles C; Bassuk JA; Pulyaeva H; Sage EH; Foidart JM; Thompson EW Cancer Res; 1998 Dec; 58(23):5529-36. PubMed ID: 9850090 [TBL] [Abstract][Full Text] [Related]
6. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells. Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081 [TBL] [Abstract][Full Text] [Related]
7. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545 [TBL] [Abstract][Full Text] [Related]
8. Stimulation of MMP-11 (stromelysin-3) expression in mouse fibroblasts by cytokines, collagen and co-culture with human breast cancer cell lines. Selvey S; Haupt LM; Thompson EW; Matthaei KI; Irving MG; Griffiths LR BMC Cancer; 2004 Jul; 4():40. PubMed ID: 15272933 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts. Sato T; Iwai M; Sakai T; Sato H; Seiki M; Mori Y; Ito A Br J Cancer; 1999 Jun; 80(8):1137-43. PubMed ID: 10376963 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596 [TBL] [Abstract][Full Text] [Related]
11. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Yu M; Sato H; Seiki M; Thompson EW Cancer Res; 1995 Aug; 55(15):3272-7. PubMed ID: 7614461 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249 [TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation mediates ConA-induced membrane type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in MDA-MB-231 human breast carcinoma cells. Yu M; Bowden ET; Sitlani J; Sato H; Seiki M; Mueller SC; Thompson EW Cancer Res; 1997 Nov; 57(22):5028-32. PubMed ID: 9371497 [TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-2 activation in human hepatic fibrosis regulation by cell-matrix interactions. Préaux AM; Mallat A; Nhieu JT; D'Ortho MP; Hembry RM; Mavier P Hepatology; 1999 Oct; 30(4):944-50. PubMed ID: 10498646 [TBL] [Abstract][Full Text] [Related]
16. Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice. Drew AF; Blick TJ; Lafleur MA; Tim EL; Robbie MJ; Rice GE; Quinn MA; Thompson EW Gynecol Oncol; 2004 Dec; 95(3):437-48. PubMed ID: 15581944 [TBL] [Abstract][Full Text] [Related]
17. Membrane-type 1 matrix metalloproteinase expression is regulated by zonula occludens-1 in human breast cancer cells. Polette M; Gilles C; Nawrocki-Raby B; Lohi J; Hunziker W; Foidart JM; Birembaut P Cancer Res; 2005 Sep; 65(17):7691-8. PubMed ID: 16140936 [TBL] [Abstract][Full Text] [Related]
18. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells. Fishman DA; Bafetti LM; Stack MS Invasion Metastasis; 1996; 16(3):150-9. PubMed ID: 9186550 [TBL] [Abstract][Full Text] [Related]
19. Elevated expression of membrane-type 1 and 3 matrix metalloproteinases in rat vascular smooth muscle cells activated by arterial injury. Shofuda K; Nagashima Y; Kawahara K; Yasumitsu H; Miki K; Miyazaki K Lab Invest; 1998 Aug; 78(8):915-23. PubMed ID: 9714179 [TBL] [Abstract][Full Text] [Related]
20. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes. Baumann P; Zigrino P; Mauch C; Breitkreutz D; Nischt R Br J Cancer; 2000 Nov; 83(10):1387-93. PubMed ID: 11044366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]